A. Machl

发表

Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers.

T. E. Richardson, F. Rohdich, B. Huck, 2021, Journal of medicinal chemistry.

DNA microarray technology and antimicrobial drug discovery.

S. Meier-Ewert, B. Seizinger, H. Loferer, 2000, Pharmacogenomics.

M 2698 is a potent dual-inhibitor of p 70 S 6 K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier

Xiaohong Liu, B. Huck, E. Wilker, 2016 .

Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial

Edward J. Kim, H. Lenz, S. Kopetz, 2022, The oncologist.

Applicability of nonsyngeneic cell models for screening of genes in monogenetics diseases via differential display technique

M. Kubbies, A. Machl, S. Planitzer, 1997, Electrophoresis.

Discovery of 4-Aminopyrimidine Analogs as highly Potent Dual P70S6K/Akt Inhibitors.

Xuliang Jiang, B. Huck, E. Wilker, 2021, Bioorganic & medicinal chemistry letters.

Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters.

Shomit Sengupta, S. J. Mahoney, E. Saiah, 2019, Cell chemical biology.

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Y. Vugmeyster, M. Borad, J. Furuse, 2023, Hepatology.

M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier.

Xiaohong Liu, B. Huck, E. Wilker, 2016, American journal of cancer research.

SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily.

S. Hosier, M. Kubbies, K. Swisshelm, 1999, Gene.